Cargando…
Leveraging the Medicines for Malaria Venture malaria and pathogen boxes to discover chemical inhibitors of East Coast fever
Chemotherapy of East Coast fever, a lymphoproliferative cancer-like disease of cattle causing significant economic losses in Africa, is largely dependent on the use of buparvaquone, a drug that was developed in the late 1980's. The disease is caused by the tick-borne protozoan pathogen Theileri...
Autores principales: | Nyagwange, James, Awino, Elias, Tijhaar, Edwin, Svitek, Nicholas, Pelle, Roger, Nene, Vishvanath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376154/ https://www.ncbi.nlm.nih.gov/pubmed/30771616 http://dx.doi.org/10.1016/j.ijpddr.2019.01.002 |
Ejemplares similares
-
Novel Antifungal Compounds Discovered in Medicines for Malaria Venture’s Malaria Box
por: Jung, Eric H., et al.
Publicado: (2018) -
Immune parameters to p67C antigen adjuvanted with ISA206VG correlate with protection against East Coast fever
por: Lacasta, Anna, et al.
Publicado: (2018) -
Antibodies to in silico selected GPI-anchored Theileria parva proteins neutralize sporozoite infection in vitro
por: Nyagwange, James, et al.
Publicado: (2018) -
Characterization of the Theileria parva sporozoite proteome
por: Nyagwange, James, et al.
Publicado: (2018) -
Screening the Medicines for Malaria Venture Pathogen Box against piroplasm parasites
por: Nugraha, Arifin Budiman, et al.
Publicado: (2019)